The independent source for health policy research, polling, and news.
21-40 of 773 results
A 2024 state law reclassified misoprostol and mifepristone as controlled substances. That affects how hospitals can access the drugs in non-abortion emergencies, and other states appear to be taking note.
A new report finds that participation in the federal food stamp program is down far more than was predicted when the Republican-led Congress approved cuts in 2025. That portends a similar fate for Medicaid, as states ready comparable changes. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine join KFF Health News’ Julie Rovner to discuss the news. Also, as part of the “How Would You Fix It?” series, Rovner interviews GOP Sen. Bill Cassidy of Louisiana, who chairs the Senate Health, Education, Labor, and Pensions Committee.
Nursing homes and assisted living facilities can be fertile ground for violence between residents with dementia, including fatal assaults. A KFF Health News examination of health reports and court records shows how warning signs are missed and safeguards fall short.
Most of the federal Medicaid cuts don’t take effect until 2027, but many states are already cutting budgets in anticipation of getting fewer health dollars from Washington. Meanwhile, Congress is back from break, but progress on legislative priorities remains slow. Anna Edney of Bloomberg News, Alice Miranda Ollstein of Politico, and Sandhya Raman of Bloomberg Law join KFF Health News’ Julie Rovner to discuss these stories and more. And as part of the “How Would You Fix It?” series, Rovner interviews Elizabeth Mitchell of the Purchaser Business Group on Health.
California’s laws still leave extradition decisions related to reproductive rights and gender-affirming care to its governor. But as states with abortion bans target California physicians who prescribe abortion pills across state lines, Democrats want to lock in protections for doctors, no matter who the next governor is.
When makers of infant formula hear that babies got sick or died while using their products, what happens next is left largely to the manufacturers. They decide whether to inform the FDA about possible harm, which could trigger steps to protect the public.
The payment by Elevance Health to the Centers for Medicare & Medicaid Services comes as the agency threatened to bar new enrollments in the company’s plans.
With the fiscal year mostly over, hundreds of millions of dollars in health-related grants approved by Congress still have not reached their designated recipients, with the Trump administration again delaying distribution. Meanwhile, on the fourth anniversary of the Supreme Court decision that allowed states to ban abortion, the number of abortions in the U.S. is actually rising. Maya Goldman of Axios, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, and Rachana Pradhan of KFF Health News join KFF Health News’ Julie Rovner to discuss these stories and more.
As a federal court mulls a case that could result in significant restrictions on a pill used in most abortions, providers say they have alternatives to preserve access even in states with bans in place.
The Trump administration has pursued an extensive pro-tobacco agenda as the president and his political movement have been buoyed by a flood of tobacco industry money, federal records show.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Adult Medicaid enrollees with serious health conditions may not be automatically exempt from new work rules, according to a new regulation from the Trump administration. Meanwhile, the administration is also proposing to give political appointees even more power over who gets health and science grant funding. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico, and Liz Essley Whyte of The Wall Street Journal join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF Health News’ Lauren Sausser, who wrote the latest “Bill of the Month.”
Immigrant detainees have told courts across the nation that detention officials have failed to treat or stabilize their conditions, from pregnancy to prostate cancer, suggesting that systemic lapses in care extend well beyond record deaths in Immigration and Customs Enforcement custody.
Several rural communities were thrust into a charged national debate over the Trump administration’s mass deportation strategy when federal officials sought to place new detention centers in them. In Social Circle, Georgia, locals fear the effort will overburden its modest healthcare infrastructure.
RaDonda Vaught was convicted of negligent homicide for accidentally dispensing a deadly drug to a patient. She now gives speeches about hospital safety in an era of automation and artificial intelligence.
As widely expected, Marty Makary stepped down as head of the FDA this week. Meanwhile, the Supreme Court weighs blocking telehealth prescriptions for the abortion pill mifepristone. Rachel Cohrs Zhang of Bloomberg News, Alice Miranda Ollstein of Politico, and Lauren Weber of The Washington Post join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Sen. Tammy Baldwin (D-Wis.).
A federal court’s decision to restrict availability of the abortion pill mifepristone has launched abortion back into the national spotlight. It’s also raised new questions about the job security of FDA Commissioner Marty Makary. Sandhya Raman of Bloomberg Law, Shefali Luthra of The 19th, and Jessie Hellmann of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more. Also, Rovner interviews KFF Health News’ Andrew Jones, who wrote the latest “Bill of the Month."
In “Hikma v. Amarin,” the Supreme Court’s decision could affect how quickly generic versions of brand-name medicines come to market.
Democrats and Republicans on a House panel that oversees Medicare had strong words about high hospital pricing at a hearing this week, but it remains unclear whether reality will match the rhetoric when it comes to reining in those prices. Meanwhile, a study found the 988 suicide prevention hotline reduced suicides significantly in its first two years. Shefali Luthra of The 19th, Rachel Roubein of The Washington Post, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine join KFF Health News’ Julie Rovner to discuss these stories and more.
Florida’s KidCare expansion has been stuck in legal limbo since February 2024. Since then, the number of uninsured children in Florida has risen to 400,000 — one of the highest state tallies.
© 2026 KFF